Neurology Articles
Neurology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Neurology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Neurology
        Basic Science/Genetics
        CNS Infectious Disease
        Critical Care
        Dementia
        Demyelinating Disorders
        Economics of Medicine
        Headache
        Movement Disorders
        Neuro/Psych pharmacology
        Neuroendocrinology
        Neurologic Oncology
        Neuropathy/Myopathy
        Neuropsych Sciences
        Neuroradiology
        Neurorehabilitation
        Neurosensory Disorders
        Neurosurgery
        Pain Medicine
        Pediatric Neurology
        Popular Press
        Seizure
        Sleep
        Spine
        Stroke/Vascular
        Trauma
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
parkinson's  parkinson's
neuritis  neuritis
neuralgia  neuralgia
myasthenia gravis  myasthenia gravis
lactic acidosis  lactic acidosis
ataxia  ataxia
seizure  seizure
tinnitus  tinnitus
migraine  migraine
hypotonia  hypotonia
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
The combined effects of Sciemed Flex Tm and brain function sqautemetry on memory and entrapment neuropathy: A neuroendocrinologic concept study
Ekwerike A et al. – Results show that the combination of Sciemed flex tablets, BrainFun Sqautemetry, and physical therapy promote mental health, entrapment release, joint flexibility, and general well being, and also show that pain inhibits cognition.

Methods

  • Sciemed Flex: neuroendocrinologic-osteologic supplementary drug designed to promote BrainFun Squatemetry: cognitive profiling and therapeutic device to measure short and long term, calculative, abstract memories
  • Subjects: 20 normal controls and 60 pts routinely diagnosed
  • Review of x-ray, MRI, ECG, EEG, and blood sample data
  • Double blind orthopedic and neurologic exams
  • Pt grouped as 4 groups of 20 pts each: normasq, Entrap, Entrapflex, and Entrapflexsq
  • Administration of Sciemed flex tab 1 × 3 daily for third and fourth groups only
  • Administration of placebo 1 × 3 daily for 30 days for normasq and Entrap groups
  • BrainFun Sqautemetry and physical therapy 3× weekly for 30 days for all groups
  • Ongoing study of 90 days, with second 30 days as recovery follow-up period
  • Pain assessment psychometry to infer neuralgia status

Results
  • Entrapflexsq group showed quicker recovery rate and better cognitive prospective orientations vs other groups
  • Entrapflex group improved more than Entrap group
  • Normasq group showed better cognitive prospective orientation vs Entrap group and measured slightly better than Entrapflex group
[more...]
Sponsor

Read a Different Specialty

General Neurology
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Neurology Article Profession Index

General Neurology
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.